KELSEY COLE: Open Payments
NPI 1013778612 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 68 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $886 · 2025 $1,508
Food & beverage: $1,210Education: $298
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $226 |
| Daiichi Sankyo Inc. | 5 | $200 |
| Incyte Corporation | 2 | $116 |
| PFIZER INC. | 7 | $114 |
| SEAGEN INC. | 1 | $99 |
| ABBVIE INC. | 5 | $90 |
| Merck Sharp & Dohme LLC | 5 | $85 |
| Janssen Biotech, Inc. | 3 | $80 |
| Eisai Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
Products named: ENHERTU, IMFINZI, KEYTRUDA, IBRANCE, Lenvima, BESREMI, KISQALI, EPKINLY.
Industry payments across AR — which companies pay providers there.
